Olema Pharmaceuticals, Inc. (OLMA) 8-K Current Report — March 16, 2026
Filed: March 16, 2026
Health Care
Pharmaceutical PreparationsOlema Pharmaceuticals, Inc. (OLMA) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Olema Pharmaceuticals, Inc. 8-K Mar 16, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Full-year 2025 financial results reported March 16, 2026
- • Full details in accompanying press release exhibit — primary source for revenue, cash, and pipeline spend figures
Get deeper insights on Olema Pharmaceuticals, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.